Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | GPBAR1 | Q8TDU6 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 3/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | CES2 | O00748 | 1/20 | 0.38 |
| ▸ | CES1 | P23141 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | ESR1 | P03372 | 1/20 | 0.35 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.35 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.35 |
| ▸ | BCL2A1 | Q16548 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4199099 | 0.84 | CES2 (0.40) | POLBGPBAR1TSHRALDH1A1SMN1; SMN2 | |
| SCHEMBL9327892 | 0.82 | POLB (0.41) | POLBGPBAR1TSHRALDH1A1SMN1; SMN2 | |
| SCHEMBL3157322 | 0.80 | GAA (0.41) | POLBGPBAR1TSHRALDH1A1SMN1; SMN2 | |
| SCHEMBL29524083 | 0.80 | GAA (0.41) | POLBGPBAR1TSHRALDH1A1SMN1; SMN2 | |
| SCHEMBL665305 | 0.78 | ALDH1A1 (0.45) | POLBTSHRALDH1A1TP53CES2 | |
| SCHEMBL12550521 | 0.78 | POLB (0.52) | POLBGPBAR1TSHRALDH1A1SMN1; SMN2 | |
| SCHEMBL28587764 | 0.78 | ALDH1A1 (0.41) | POLBGPBAR1TSHRALDH1A1SMN1; SMN2 | |
| SCHEMBL6002883 | 0.78 | CES2 (0.41) | POLBGPBAR1TSHRALDH1A1SMN1; SMN2 | |
| SCHEMBL1624396 | 0.77 | GPBAR1 (0.44) | POLBGPBAR1TSHRALDH1A1SMN1; SMN2 | |
| SCHEMBL10875540 | 0.77 | TSHR (0.45) | POLBGPBAR1TSHRALDH1A1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 378 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2551309-B1 | ANTIFOULING COATING COMPOSITION AND USE FOR SAME | CHUGOKU MARINE PAINTS (JP) | 2017-05-17 | — | — | EP | claimed |
| US-8840910-B2 | Antifouling coating composition and uses of the same | CHUGOKU MARINE PAINTS, LTD. (JP) | 2014-09-23 | — | — | US | claimed |
| US-20130045264-A1 | ANTIFOULING COATING COMPOSITION AND USES OF THE SAME | CHUGOKU MARINE PAINTS, LTD. (JP) | 2013-02-21 | — | — | US | claimed |
| EP-2551309-A1 | ANTIFOULING COATING COMPOSITION AND USE FOR SAME | Chugoku Marine Paints, Ltd. (JP) | 2013-01-30 | — | — | EP | claimed |
| EP-2343975-B1 | SPINOSYN ANTIFOULING COMPOSITIONS, METHODS OF USE THEREOF AND ARTICLES PROTECTED FROM ATTACHMENT OF BIOFOULING ORGANISMS | ENTARCO SA (GR) | 2012-09-12 | — | — | EP | claimed |
| US-8153705-B2 | Silyl esters, their use in binder systems and paint compositions and a process for production thereof | SIGMAKALON B.V. (NL) | 2012-04-10 | — | — | US | claimed |
| US-8148446-B2 | Silyl esters, their use in binder systems and paint compositions and a process of production thereof | SIGMAKALON B.V. (NL) | 2012-04-03 | — | — | US | claimed |
| US-7934888-B2 | Marine anti-foulant system and methods for using same | VIV SUPPRESSION, INC. (US) | 2011-05-03 | — | — | US | claimed |
| US-20100240800-A1 | BIOCIDAL ELASTOMERIC COMPOSITIONS AND METHODS OF MAKING THE SAME | DASH MULTI-CORP (US) | 2010-09-23 | — | — | US | claimed |
| US-20100209381-A1 | COPPER COMPOUND-CONTAINING ANTIFOULING COATING COMPOSITION HAVING IMPROVED SLIME RESISTANCE AND STORAGE STABILITY | CHUGOKU MARINE PAINTS, LTD. (JP) | 2010-08-19 | — | — | US | claimed |
| EP-0954965-A1 | Controlled release compositions | ROHM AND HAAS COMPANY (US) | 1999-11-10 | — | — | EP | claimed |
| EP-0954966-A1 | Polymeric controlled release compositions | ROHM AND HAAS COMPANY (US) | 1999-11-10 | — | — | EP | claimed |
| EP-0922386-A2 | Controlled release compositions | ROHM AND HAAS COMPANY (US) | 1999-06-16 | — | — | EP | claimed |
| US-5855654-A | APPLYING (DIHYDRO)PYRIDAZINONE COMPOUND | ROHM AND HAAS COMPANY (US) | 1999-01-05 | — | — | US | claimed |
| EP-0880892-A1 | Controlled release compositions | ROHM AND HAAS COMPANY (US) | 1998-12-02 | — | — | EP | claimed |
| US-5833742-A | APPLYING ONTO OR INTO MARINE STRUCTURE A MICROBIOCIDES TO INHIBIT THE ORGANISM GROWTH | ROHM AND HAAS COMPANY (US) | 1998-11-10 | — | — | US | claimed |
| EP-0856255-A2 | Pyridazinones as marine antifouling agents | ROHM AND HAAS COMPANY (US) | 1998-08-05 | — | — | EP | claimed |
| EP-0835604-A1 | Halopropargyl compounds as marine antifouling agents | ROHM AND HAAS COMPANY (US) | 1998-04-15 | — | — | EP | claimed |
| EP-0835605-A1 | Phenylamides as marine antifouling agents | ROHM AND HAAS COMPANY (US) | 1998-04-15 | — | — | EP | claimed |
| US-5221331-A | Of a metal salt of hexamethylenedithiocarbamic acid, vehicle, solvent and additives | ROHM AND HAAS COMPANY (US) | 1993-06-22 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130045264-A1 | ANTIFOULING COATING COMPOSITION AND USES OF THE SAME | ADRB2, OPRM1, CHRM2 | POLB 413/4885GPBAR1 712/4885TSHR 1486/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.